Culture

Eliminating copayments improves adherence, reduces adverse events in nonwhite patients

Research demonstrates that lowering copayments for cardiovascular medications results in better adherence and outcomes among all patients, but until now, little was known about whether lowering copayments could improve known disparities in cardiovascular care. New research finds that lowering copayments for medications following a heart attack could have a significant impact on reducing the racial and ethnic disparities that exist in cardiovascular disease.

These findings are published in the May issue of Health Affairs.

NeuroStar TMS Therapy shows promise as maintenance therapy for major depression

NEW YORK, May 5, 2014 – Neuronetics, Inc. announced today results from a new, dual-arm randomized pilot study that showed a trend toward symptomatic improvements with once-monthly TMS maintenance therapy in medication-free patients treated with NeuroStar TMS Therapy® for Major Depressive Disorder (MDD). Six weeks of acute NeuroStar TMS Therapy induced remission in 61.2 percent of all enrolled patients.

Focused ultrasound reduces cancer pain

(PHILADELPHIA)—When cancer progresses and spreads to the bone, patients often suffer debilitating pain. Now, a new phase III clinical trial shows that non-invasive magnetic resonance guided focused ultrasound treatment that heats the cancer within the bone, relieves pain and improves function for most patients when other treatment options are limited. The results were published in the Journal of the National Cancer Institute (JNCI).

Test that measures 'everyday task' performance is a good predictor of hospital readmission

Patients freshly discharged from acute care hospitals with low scores on a standard test that measures how well they perform such everyday activities as moving from a bed to a chair are far more likely to need readmission to a hospital within 30 days than those who score better, according to new Johns Hopkins research.

'Severe escalation' of anti-Jewish atmosphere in 2013

Tel Aviv — Despite a 20% decline in the number of violent incidents against Jews, last year saw a sharp rise in abusive language and behavior, threats, and harassment of Jewish people on an individual basis around the world, according to the annual report presented on April 27, 2014, by Tel Aviv University's Kantor Center for the Study of Contemporary European Jewry and the Moshe Kantor Database for the Study of Contemporary Antisemitism and Racism, in cooperation with the European Jewish Congress.

Soy sauce molecule may unlock drug therapy for HIV patients

COLUMBIA, Mo. – For HIV patients being treated with anti-AIDS medications, resistance to drug therapy regimens is commonplace. Often, patients develop resistance to first-line drug therapies, such as Tenofovir, and are forced to adopt more potent medications. Virologists at the University of Missouri now are testing the next generation of medications that stop HIV from spreading, and are using a molecule related to flavor enhancers found in soy sauce, to develop compounds that are more potent than Tenofovir.

Virtual patients, medical records and sleep queries may help reduce suicide

AUGUSTA, Ga. - A virtual patient, the electronic medical record, and questions about how well patients sleep appear effective new tools in recognizing suicide risk, researchers say.

A fourth – and perhaps more powerful – tool against suicide is the comfort level of caregivers and family members in talking openly about it, said Dr. W. Vaughn McCall, Chairman of the Department of Psychiatry and Health Behavior at the Medical College of Georgia at Georgia Regents University.

Dual method to remove precancerous colon polyps may substantially reduce health-care costs

Chicago, IL (May 5, 2014) — A surgical method combining two techniques for removing precancerous polyps during colonoscopies can substantially reduce the recovery time and the length of hospital stays, potentially saving the health-care system millions of dollars, according to research presented today at Digestive Disease Week® (DDW).

Minneapolis Heart Institute Foundation implants its 1st world's smallest cardiac pacemaker

MINNEAPOLIS, MN – May 1, 2014 – The Minneapolis Heart Institute Foundation (MHIF) announced today the first implant of the world's smallest pacemaker at the Minneapolis Heart Institute. The device was implanted as part of a global clinical trial and the procedure was the first of its kind in the Midwest.

Lean patients with fatty liver disease have higher mortality rate

Chicago, IL (May 4, 2014) — Despite being of a healthier weight, lean patients with nonalcoholic fatty liver disease (NAFLD) have a higher overall mortality rate than patients with NAFLD who are overweight or obese, according to new research presented today at Digestive Disease Week® (DDW). In addition to finding higher mortality rates, an international team of researchers found that lean patients [a body mass index (BMI) less than 25] with NAFLD were more likely to be male, non-Caucasian and to have lower rates of chronic conditions, such as diabetes and hypertension.

Study points to potential revision of treatment guidelines for bleeding ulcers

Chicago, IL (May 4, 2014) — The current standard of care for managing patients who receive endoscopic treatment for bleeding ulcers should be replaced by an equally safe and less costly alternative that is more comfortable for patients, according to new research presented today at Digestive Disease Week® (DDW).

Scores of bullying victims bringing weapons to school

VANCOUVER, BRITISH COLUMBIA – An estimated 200,000 high school students who are bullied bring weapons to school, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.

Researchers also found that youths who have been victimized in multiple ways are up to 31 times more likely to carry a weapon to school than those who have not been bullied.

Vibrating capsule shows promising results in treating chronic constipation

Chicago, IL (May 3, 2014) — An oral capsule that vibrates as it moves through the digestive tract has shown notable promise as a non-pharmacological treatment for constipation, according to new research presented today at Digestive Disease Week® (DDW). In the pilot study, the vibrating capsule was found to nearly double the weekly bowel movements of patients suffering from chronic idiopathic constipation (CIC) and constipation predominant irritable bowel syndrome (C-IBS).

Nearly 50 percent of M.D.s believe diversion of ADHD stimulant medications among teens is a problem

VANCOUVER, BC – Two recent studies by investigators at the Cohen Children's Medical Center of New York examined physicians' perceptions and knowledge of diversion of stimulant medications for Attention Deficit Hyperactivity Disorder (ADHD) as well as practices physicians use to prevent diversion among their patients prescribed these medications.

Drinking poses greater risk for advanced liver disease in HIV/hep C patients

PHILADELPHIA—Consumption of alcohol has long been associated with an increased risk of advanced liver fibrosis, but a new study published online in Clinical Infectious Diseases from researchers at Penn Medicine and other institutions shows that association is drastically heightened in people co-infected with both HIV and chronic hepatitis C virus (HCV) infection.